Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

FRA/9EN stock hub

FRA/9EN has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/9ENis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.7B

Frankfurt Stock Exchange

Market data

Price

Recent price action with selectable time range.

FRA/9ENFRA/9EN

—

Loading chart…

In the news

Latest news · FRA/9EN

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-65.2

P25 n/aP50 n/aP75 n/a

ROIC-39.3

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/9EN market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

144

Groups with data

Currency

EUR

Showing 144 of 144 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Netherlands
Country code	DE
Employees	129
Employees Change	21%
Employees Change Percent	19.44
Enterprise value	EUR 1.4B
Exchange	Frankfurt Stock Exchange
Financial currency	EUR
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-05-10
Market cap	EUR 1.7B
Price	EUR 25.45
Price currency	EUR
Sic	2836
Symbol	fra/9EN
Website	https://pharvaris.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-10.51%
EV Earnings	-7.87x
EV/FCF	-10.07x
FCF yield	-8.21%
P/B ratio	6.16x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	EUR -175.7M
Profit Per Employee	EUR -1.4M
ROA	-35.81
Roa5y	-26.75
ROCE	-62.47
ROE	-65.19
Roe5y	-43.14
ROIC	-39.26

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	68.6%
Cagr3y	46.45%
Cagr5y	6.36%

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	EUR 301.5M
Cash	EUR 291.7M
Current Assets	EUR 299.2M
Current Liabilities	EUR 29.6M
Debt	EUR 776,798
Debt Equity	EUR 0
Debt FCF	EUR -0.01
Equity	EUR 271.3M
Interest Coverage	-982.4
Liabilities	EUR 30.2M
Long Term Assets	EUR 2.3M
Long Term Liabilities	EUR 576,585
Net Cash	EUR 290.9M
Net Cash By Market Cap	EUR 17.4
Net Cash Growth	3.94%
Net Debt Equity	EUR -1.07
Tangible Book Value	EUR 271.3M
Tangible Book Value Per Share	EUR 4.16

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	10.11
Net Working Capital	EUR -21.9M
Quick ratio	10.01
Working Capital	EUR 269.6M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-9.51%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	68.54%
200-day SMA	21.33
3Y total return	214.2%
50-day SMA	23.69
50-day SMA vs 200-day SMA	50over200
5Y total return	36.1%
All Time High	32.5
All Time High Change	-21.69%
All Time High Date	2021-02-26
All Time Low	1.87
All Time Low Change	1,260.96%
All Time Low Date	2022-12-05
ATR	1.13
Ch YTD	17.82
High	25.9
High52	26.3
High52 Date	2026-04-30
High52ch	-3.23%
Low	24.85
Low52	12.7
Low52 Date	2025-05-15
Low52ch	100.39%
Ma50ch	7.42%
Price vs 200-day SMA	19.31%
RSI	56.6
RSI Monthly	60.2
RSI Weekly	63.44
Sharpe ratio	1.13x
Sortino ratio	2.06
Total Return	-9.51%
Tr YTD	17.82
Tr1m	6.49%
Tr1w	-0.59%
Tr3m	15.68%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -169.8M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	35,184,449%
Net Borrowing	-219,013
Shares Insiders	3.27%
Shares Institutions	53.32%
Shares Qo Q	4.6%
Shares Yo Y	9.51%
Short Ratio	5.18

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -156.3M
Average Volume	92.3x
Bv Per Share	4.16
CAPEX	EUR -164,619
Ch1m	6.49
Ch1w	-0.59
Ch1y	68.54
Ch3m	15.68
Ch3y	214.2
Ch5y	36.1
Ch6m	36.83
Change	2%
Change From Open	2.41
Close	24.95
Days Gap	-0.4
Depreciation Amortization	189,150
Earnings Date	2026-08-13
EBIT	EUR -169.8M
EBITDA	EUR -169.6M
EPS	EUR -2.97
F Score	1
FCF	EUR -137.2M
FCF EV Yield	-9.93x
Financing CF	160,607,219
Fiscal Year End	December
Founded	2,015
Income Tax	EUR 2M
Investing CF	-164,619
Is Primary Listing	0
Last Earnings Date	2025-11-20
Last Report Date	2025-12-31
Ma150	22.06
Ma150ch	15.35%
Ma20	24.66
Ma20ch	3.2%
Net CF	10,950,851
Next Earnings Date	2026-08-13
Open	24.85
Position In Range	57.14
Ppne	1,399,421
Price Date	2026-05-08
Ptbv Ratio	6.16
Relative Volume	72.3x
Share Based Comp	19,050,394
Tr6m	36.83%
Volume	0

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does FRA/9EN pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/9EN stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/9EN?

Insider, institutional, and short-interest positioning.

Institutional ownership

+53.3%

Share of float held by funds and institutions

Insider ownership

+3.3%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

FRA/9EN momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

56.6

Neutral momentum band

Price vs 200-day MA

+19.3%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

1.13

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/9EN

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/9EN stock rating?

fra/9EN is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/9EN analysis?

The full report lives at /stocks/fra/9EN/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/9EN?

The latest report frames fra/9EN around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/9EN page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.